|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Operations and support | |||
| Research and development | |||
| Sales and marketing | |||
| General and administrative | |||
| Total operating expenses | |||
| Income (loss) from operations | |||
| Other income (expense), net | |||
| Interest income | |||
| Income (loss) before provision for (benefit from) income taxes | |||
| Provision for (benefit from) income taxes | |||
| Net income (loss) | |||
| Undistributed earnings attributable to preferred stockholders | |||
| Accretion related to Series A redeemable convertible preferred stock | |||
| Net income (loss) attributable to common stockholders, basic | |||
| Undistributed earnings reallocated to common stockholders | |||
| Net income (loss) attributable to common stockholders, diluted | |||
| Net income (loss) per share attributable to common stockholders: | |||
| Basic (in dollars per share) | |||
| Diluted (in dollars per share) | |||
| Net income (loss) per share attributable to common stockholders: | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...
